The Noerr-Pennington doctrine is an antitrust immunity that protects businesses and individuals when they ask the government to act, even when the action they want would hurt a competitor. It grows out of the First Amendment right to petition, and it covers lobbying legislators, pressing agencies for favorable regulations, and filing lawsuits. The shield is broad but not unlimited. Sham petitioning, fraud on a government decision-maker, and private commercial conduct that only looks political can all fall outside it.
Where the Doctrine Comes From
Two Supreme Court decisions give the doctrine its name. In Eastern Railroad Presidents Conference v. Noerr Motor Freight, Inc., 365 U.S. 127 (1961), the Court held that the Sherman Act does not bar groups from joining together to persuade a legislature or executive to take action, even action that would produce a monopoly.1Library of Congress. Eastern Railroad Presidents Conference v. Noerr Motor Freight, Inc., 365 U.S. 127 Four years later, United Mine Workers of America v. Pennington, 381 U.S. 657 (1965), extended the same protection to lobbying aimed at executive officials and made clear that the petitioner’s motive does not matter. Whether the aim is genuine public concern or driving a rival out of business, asking the government to act remains protected.2Library of Congress. United Mine Workers of America v. Pennington, 381 U.S. 657
The underlying principle surprises many people. The law prioritizes the government’s need to hear from interested parties over the goal of maintaining perfectly competitive markets. A company can openly push for a rule that would crush its rivals. As long as it is genuinely seeking a government decision, antitrust law stays out of the way.
What the Doctrine Protects
Lobbying Legislators and Agencies
Companies routinely lobby lawmakers, testify at hearings, and run public campaigns to shape legislation. All of that is protected from antitrust challenge, even if the resulting law creates barriers to entry that only the lobbying company can clear. The same applies to the executive branch, including administrative agencies. Seeking favorable regulations, requesting permits, or asking an agency to investigate a competitor are all treated as petitioning the government to use its sovereign authority.
The key factor is whether the government retains discretion over the outcome. When a business asks a regulator to exercise judgment, weigh evidence, or make a policy decision, that request is protected. The FTC has drawn a line at filings that trigger only a mechanical or ministerial government response, such as certain tariff filings where the agency has no real discretion and simply processes the paperwork. Those are not treated as petitioning because they do not involve persuading a decision-maker to act.3Federal Trade Commission. Enforcement Perspectives on the Noerr-Pennington Doctrine
Using the Courts
Litigation is petitioning too. In California Motor Transport Co. v. Trucking Unlimited, 404 U.S. 508 (1972), the Supreme Court held that the right to petition “extends to all departments of the Government,” and that access to the courts “is indeed but one aspect of the right of petition.”4Library of Congress. California Motor Transport Co. v. Trucking Unlimited, 404 U.S. 508 A patent infringement suit, a challenge to a competitor’s license, or an environmental complaint filed with an agency all fall within the doctrine’s reach. Even when a lawsuit is filed primarily to defend market share, the act of using the legal system is shielded.
The Sham Exception
Protection disappears when petitioning is a sham, meaning the party is not really seeking a government decision but using the process itself as a weapon. The Supreme Court set the standard in Professional Real Estate Investors, Inc. v. Columbia Pictures Industries, Inc., 508 U.S. 49 (1993), with a two-part test.5Legal Information Institute. Professional Real Estate Investors, Inc. v. Columbia Pictures Industries, Inc.
The first question is whether the lawsuit or petition is objectively baseless. It must be one that no reasonable party could realistically expect to win on the merits. If there is any legitimate legal basis, immunity holds regardless of motive. Only if that first prong is met does a court reach the second question: whether the party used the government process as an anticompetitive weapon, aiming to harm a rival through the cost and delay of the proceeding rather than through whatever the government might ultimately decide.
The first prong is a high bar by design. A lawsuit that loses, even one that loses badly, is not automatically objectively baseless. And a lawsuit that wins is by definition not a sham. That keeps the exception narrow. Courts apply it where the petitioning is so devoid of merit that harassment is the only plausible explanation.
Serial Filings and the Circuit Split
The two-part test was built for evaluating a single lawsuit. A harder question comes up when a company files a string of complaints or lawsuits against a competitor, where each filing might have just enough merit to survive review but the overall pattern looks designed to bury the rival in legal costs.
Some federal circuits, including the Second and Ninth, have taken a different approach for that scenario. Rather than requiring each filing to be objectively baseless on its own, they ask whether the filings were brought “pursuant to a policy of starting legal proceedings without regard to the merits and for the purpose of injuring a market rival.”3Federal Trade Commission. Enforcement Perspectives on the Noerr-Pennington Doctrine The FTC has endorsed that more flexible test for serial litigation. Not every circuit agrees. Some still require each filing in the series to independently meet the PRE standard, so the strength of a serial-litigation antitrust claim depends in part on where the case is filed.
Pharmaceutical Citizen Petitions
FDA citizen petitions have become a common testing ground for the sham exception. Brand-name drug makers sometimes file petitions raising safety or bioequivalence concerns about pending generic versions of their drugs. If the petition has a legitimate scientific basis, it is protected even if it delays generic approval. Courts have allowed antitrust claims to proceed, however, where the evidence suggests the petition was objectively baseless and filed solely to buy time. GlaxoSmithKline faced antitrust scrutiny after filing citizen petitions raising safety questions about its own drug Flonase in an effort to delay a generic version. The court found genuine factual disputes about whether the petitions were objectively baseless and denied summary judgment.
Fraud on a Government Decision-Maker
Lying to the government can also strip away immunity, though the exact contours are still contested. The clearest application is in patent law. In Walker Process Equipment, Inc. v. Food Machinery & Chemical Corp., 382 U.S. 172 (1965), the Supreme Court held that enforcing a patent obtained through intentional fraud on the Patent Office can violate the Sherman Act’s prohibition on monopolization, provided the other elements of a monopolization claim are present.6Legal Information Institute. Walker Process Equipment, Inc. v. Food Machinery and Chemical Corp., 382 U.S. 172 (1965) An honest mistake about patentability is not enough. The fraud must be knowing and willful, and the patent must have real exclusionary power in the relevant market.
Outside the patent context, the FTC has argued for a broader misrepresentation exception that applies whenever a party makes deliberate, factually verifiable false statements that are central to the outcome of a government proceeding. Under the framework the Commission applied in its Unocal decision, protection is lost when the misrepresentation distorts a non-political government process and its effect can be shown without undermining the credibility of the agency that was deceived.3Federal Trade Commission. Enforcement Perspectives on the Noerr-Pennington Doctrine The political versus non-political distinction does work here. In legislative lobbying, exaggeration and spin are expected, and government discretion is broad. In an adjudicative or regulatory proceeding, the decision-maker relies on an evidentiary record, and a deliberate falsehood can directly produce the wrong outcome.
The Supreme Court has never definitively ruled that misrepresentation alone, outside of patent fraud, is a standalone exception to Noerr-Pennington immunity. Some circuits have recognized it. Others have declined. It remains an evolving area.
Commercial Activity Dressed Up as Petitioning
Noerr-Pennington protects efforts to influence the government. It does not protect private commercial conduct just because that conduct has political side effects. The Supreme Court drew this line in Allied Tube & Conduit Corp. v. Indian Head, Inc., 486 U.S. 492 (1988). Allied Tube had recruited hundreds of new members to the National Fire Protection Association and bused them to the annual meeting to vote against approving a competitor’s polyvinyl chloride conduit for the Association’s electrical code. Because state and local governments routinely adopted the code into law, Allied Tube argued its conduct amounted to political petitioning.7Legal Information Institute. Allied Tube and Conduit Corp. v. Indian Head, Inc., 486 U.S. 492 (1988)
The Court rejected the argument. No government had given the Association official authority. Its decision-making body included people with direct economic incentives to restrain competition, and the standard had independent force in the marketplace even before any government adopted it. The restraint came from private action, not government action, and Noerr did not apply. The takeaway is direct: influencing a private organization that later influences the government is not the same as petitioning the government, and the former carries real antitrust exposure.
Why the Exceptions Are So Costly
When conduct falls outside the doctrine’s protection, the full weight of federal antitrust law applies. The Sherman Act prohibits contracts, combinations, and conspiracies that restrain trade, with criminal penalties that can reach $100 million for a corporation.8Office of the Law Revision Counsel. 15 U.S. Code 1 – Trusts, Etc., in Restraint of Trade Illegal On the civil side, any person injured by an antitrust violation can recover three times the actual damages sustained, plus the cost of the lawsuit including a reasonable attorney’s fee.9Office of the Law Revision Counsel. 15 USC 15 – Suits by Persons Injured
Treble damages are what make the loss of immunity so painful. A competitor shut out of a market for years can calculate lost profits, multiply by three, and add attorney’s fees. In industries like pharmaceuticals, where a few months of delayed generic entry can mean hundreds of millions in sales, exposure from a successful sham-litigation or fraud claim is enormous. The exceptions are narrow. The cost of landing inside one is not.